Valuation often hinges on critical company-specific statistical and methodological decisions, raising questions about their necessity or potential for manipulation. This session examines such topics as mean vs. median, discounts for lack of marketability, premiums for control, and size premiums and company-specific premiums, and offers insights into how these decisions shape valuation outcomes.